Western blot analysis performed on soluble fractions confirmed that SOD1 level is significantly increased (p<0.05) in the nuclear compartment of ALS patients (Figures 2A left panel and 2B), compared to CTR and AD. This evidence concerns the gene SOD1 and Alzheimer disease.